These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15519835)

  • 1. [Secondary surfactant deficiencies in extremely low birth weight premature infants].
    Rivera S; Gaugler C; Langlet C; Villega F; Astruc D; Escande B; Kuhn P; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1346-50. PubMed ID: 15519835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary surfactant deficiency in neonates.
    Bissinger R; Carlson C; Hulsey T; Eicher D
    J Perinatol; 2004 Oct; 24(10):663-6. PubMed ID: 15229621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use and efficacy of treatment with porcine surfactant in newborns with birth weight < or = 1000 g: experience in 3 years].
    Brusamento S; Buffo M; Carnielli VP
    Pediatr Med Chir; 1999; 21(6):261-5. PubMed ID: 11293146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary surfactant administration in neonates with respiratory decompensation.
    Bissinger R; Carlson C; Michel Y; Dooley C; Hulsey T; Jenkins D
    J Perinatol; 2008 Mar; 28(3):192-8. PubMed ID: 18235534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the combination of primary high-frequency oscillation ventilation and prophylactic surfactant therapy improve the prognosis for extremely low birth weight infants?].
    Kribs A; Devenge J; Hünseler C; Roth B
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):190-6. PubMed ID: 15508053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates.
    Fiori HH; Fritscher CC; Fiori RM
    J Perinat Med; 2006; 34(1):66-70. PubMed ID: 16489887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant replacement therapy for respiratory distress syndrome. American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 1999 Mar; 103(3):684-5. PubMed ID: 10049980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of surfactant administration time on the outcomes in low and extremely low birth weight neonates].
    Mostovoĭ AV; Aleksandrovich IuS; Sapun OI; Trifonova EG; Tret'iakova EP; Bogdanova RZ; Karpova AL
    Anesteziol Reanimatol; 2009; (1):43-6. PubMed ID: 19348328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of exogenous surfactant in premature very low birth weight infants with RDS].
    Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A
    Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Other indications for surfactant].
    Proença Fernandes E; Carvalho C; Silva A; Ferreira P; Alegria A; Lopes L; Areias MA
    An Esp Pediatr; 2002 Jan; 56(1):45-8. PubMed ID: 11792244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
    Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
    Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome.
    Tsao PN; Wei SC; Chou HC; Su YN; Chen CY; Hsieh FJ; Hsieh WS
    Pediatr Pulmonol; 2005 May; 39(5):461-5. PubMed ID: 15786439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current trials in the treatment of respiratory failure in preterm infants.
    Soll RF
    Neonatology; 2009; 95(4):368-72. PubMed ID: 19494559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.